论文部分内容阅读
本研究测定了３２例膀胱癌和２６例前列腺增生症患者外周血ＮＫ细胞活性，并将膀胱癌组ＮＫ细胞活性分别与正常对照组及前列腺增生症组进行比较，其结果表明膀胱癌患者的ＮＫ细胞活性（３８．９１±２．２３％）比对照组（５０．９１±１．６６％）明显低，（Ｐ＜０．０１）与前列腺增生症组（４９．２７±２．３０％）相比亦有显著差异（Ｐ＜０．０１）。
This study measured the 32 cases of bladder cancer and 26 cases of benign prostatic hyperplasia patients with peripheral NK cell activity and NK cell activity of bladder cancer group were compared with the normal control group and benign prostatic hyperplasia group, the results showed that bladder cancer patients with NK The cell viability (38.91 ± 2.23%) was significantly lower than that of the control group (50.91 ± 1.66%) (P <0.01) and benign prostatic hyperplasia group (49.27 ± 2.30% There was also a significant difference (P <0.01).